Onconova Therapeutics, a US-based anti-cancer drugs developer backed in India-based peer Cadila Healthcare, has raised $50m, according to a regulatory filing. News provider Philadelphia Business Journal reports that the developer raised $26.4m in a two-part raise earlier in the year. Investors currently represented on the Onconova’s board include Cadila Healthcare, and venture capital firms ICICI Ventures (part of Indian financial services group ICICI), Starec and Naftali, Tinicum Partners and Mehta Partners.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?